TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs61747867
log Bayes Factor = 17.8895
Chromosome 6   position 26,272,548  (GRCh37) Explore rs61747867 on Ensembl!
Variant rs61747867 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.185 0.815
E10-E14 Diabetes mellitus
0.000 0.193 0.807
E11 Non-insulin-dependent diabetes mellitus
0.000 0.201 0.799
E10.9 Without complications
0.000 0.221 0.779
E10.1 With ketoacidosis
0.000 0.243 0.757
E10.3 With ophthalmic complications
0.000 0.264 0.736
E10.5 With peripheral circulatory complications
0.000 0.272 0.728
E83 Disorders of mineral metabolism
0.000 0.275 0.725
E11.2 With renal complications
0.000 0.282 0.718
K90.0 Coeliac disease
0.000 0.284 0.716
E11.5 With peripheral circulatory complications
0.000 0.286 0.714
E10.0 With coma
0.000 0.290 0.710
E11.4 With neurological complications
0.000 0.326 0.674
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.329 0.671
E70-E90 Metabolic disorders
0.000 0.340 0.660
E11.3 With ophthalmic complications
0.000 0.343 0.657
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.345 0.655
E11.6 With other specified complications
0.000 0.353 0.647
E11.1 With ketoacidosis
0.000 0.354 0.646
E16 Other disorders of pancreatic internal secretion
0.000 0.356 0.644
E16.2 Hypoglycaemia, unspecified
0.000 0.361 0.639
E11.9 Without complications
0.000 0.362 0.638
E10.2 With renal complications
0.000 0.380 0.620
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.395 0.605
E10.4 With neurological complications
0.000 0.397 0.603
E10.8 With unspecified complications
0.000 0.401 0.599
E10.7 With multiple complications
0.000 0.416 0.584
E12 Malnutrition-related diabetes mellitus
0.000 0.422 0.578
E11.7 With multiple complications
0.000 0.427 0.573
E13 Other specified diabetes mellitus
0.000 0.431 0.569
E80.4 Gilbert's syndrome
0.000 0.433 0.567
E40-E46 Malnutrition
0.000 0.458 0.542
E83.4 Disorders of magnesium metabolism
0.000 0.476 0.524
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.480 0.520
E83.8 Other disorders of mineral metabolism
0.000 0.480 0.520
E83.2 Disorders of zinc metabolism
0.000 0.480 0.520
E83.0 Disorders of copper metabolism
0.000 0.480 0.520
E11.0 With coma
0.000 0.483 0.516
E14 Unspecified diabetes mellitus
0.000 0.488 0.512
E73 Lactose intolerance
0.000 0.489 0.511
E11.8 With unspecified complications
0.000 0.501 0.499
K90 Intestinal malabsorption
0.000 0.503 0.497
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.511 0.489
E83.3 Disorders of phosphorus metabolism
0.000 0.517 0.483
E84 Cystic fibrosis
0.000 0.527 0.473
E77 Disorders of glycoprotein metabolism
0.000 0.527 0.473
E76 Disorders of glycosaminoglycan metabolism
0.000 0.527 0.473
E72 Other disorders of amino-acid metabolism
0.000 0.527 0.473
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.527 0.473
E70 Disorders of aromatic amino-acid metabolism
0.000 0.527 0.473
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.527 0.473
E15 Nondiabetic hypoglycaemic coma
0.000 0.530 0.470
E14.3 With ophthalmic complications
0.000 0.530 0.470
E79 Disorders of purine and pyrimidine metabolism
0.000 0.535 0.465
E74 Other disorders of carbohydrate metabolism
0.000 0.537 0.463
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.538 0.462
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.538 0.462
E16.4 Abnormal secretion of gastrin
0.000 0.538 0.462
E16.3 Increased secretion of glucagon
0.000 0.538 0.462
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.543 0.457
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.545 0.455
E46 Unspecified protein-energy malnutrition
0.000 0.551 0.448
E80.6 Other disorders of bilirubin metabolism
0.000 0.556 0.444
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.566 0.434
E80.5 Crigler-Najjar syndrome
0.000 0.566 0.434
E80.3 Defects of catalase and peroxydase
0.000 0.566 0.434
E80.1 Porphyria cutanea tarda
0.000 0.566 0.434
E80.0 Hereditary erythropoietic porphyria
0.000 0.566 0.434
E10.6 With other specified complications
0.000 0.583 0.417
E80.2 Other porphyria
0.000 0.584 0.416
E12.9 Without complications
0.000 0.585 0.415
E12.8 With unspecified complications
0.000 0.585 0.415
E12.7 With multiple complications
0.000 0.585 0.415
E12.6 With other specified complications
0.000 0.585 0.415
E12.5 With peripheral circulatory complications
0.000 0.585 0.415
E12.4 With neurological complications
0.000 0.585 0.415
E12.3 With ophthalmic complications
0.000 0.585 0.415
E12.2 With renal complications
0.000 0.585 0.415
E12.1 With ketoacidosis
0.000 0.585 0.415
E12.0 With coma
0.000 0.585 0.415
E85 Amyloidosis
0.000 0.586 0.413
E13.8 With unspecified complications
0.000 0.592 0.408
E13.7 With multiple complications
0.000 0.592 0.408
E13.6 With other specified complications
0.000 0.592 0.408
E13.5 With peripheral circulatory complications
0.000 0.592 0.408
E13.4 With neurological complications
0.000 0.592 0.408
E13.3 With ophthalmic complications
0.000 0.592 0.408
E13.2 With renal complications
0.000 0.592 0.408
E13.1 With ketoacidosis
0.000 0.592 0.408
E13.0 With coma
0.000 0.592 0.408
E73.9 Lactose intolerance, unspecified
0.000 0.596 0.404
K90.9 Intestinal malabsorption, unspecified
0.000 0.597 0.403
E13.9 Without complications
0.000 0.601 0.399
E88 Other metabolic disorders
0.000 0.607 0.393
E16.1 Other hypoglycaemia
0.000 0.611 0.389
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.612 0.388
E45 Retarded development following protein-energy malnutrition
0.000 0.612 0.388
E43 Unspecified severe protein-energy malnutrition
0.000 0.612 0.388
E42 Marasmic kwashiorkor
0.000 0.612 0.388
E41 Nutritional marasmus
0.000 0.612 0.388
E40 Kwashiorkor
0.000 0.612 0.388
E14.8 With unspecified complications
0.000 0.624 0.376
E14.4 With neurological complications
0.000 0.630 0.370
E14.7 With multiple complications
0.000 0.633 0.367
E14.6 With other specified complications
0.000 0.633 0.367
E14.5 With peripheral circulatory complications
0.000 0.633 0.367
E14.1 With ketoacidosis
0.000 0.633 0.367
E14.0 With coma
0.000 0.633 0.367
E73.8 Other lactose intolerance
0.000 0.634 0.366
E73.1 Secondary lactase deficiency
0.000 0.634 0.366
E73.0 Congenital lactase deficiency
0.000 0.634 0.366
K90.3 Pancreatic steatorrhoea
0.000 0.643 0.357
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.643 0.357
K90.1 Tropical sprue
0.000 0.643 0.357
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.661 0.339
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.661 0.339
E70.3 Albinism
0.000 0.661 0.339
E70.2 Disorders of tyrosine metabolism
0.000 0.661 0.339
E70.1 Other hyperphenylalaninaemias
0.000 0.661 0.339
E70.0 Classical phenylketonuria
0.000 0.661 0.339
E71.3 Disorders of fatty-acid metabolism
0.000 0.661 0.339
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.661 0.339
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.661 0.339
E71.0 Maple-syrup-urine disease
0.000 0.661 0.339
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.661 0.339
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.661 0.339
E72.5 Disorders of glycine metabolism
0.000 0.661 0.339
E72.4 Disorders of ornithine metabolism
0.000 0.661 0.339
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.661 0.339
E72.2 Disorders of urea cycle metabolism
0.000 0.661 0.339
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.661 0.339
E72.0 Disorders of amino-acid transport
0.000 0.661 0.339
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.661 0.339
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.661 0.339
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.661 0.339
E76.2 Other mucopolysaccharidoses
0.000 0.661 0.339
E76.1 Mucopolysaccharidosis, type II
0.000 0.661 0.339
E76.0 Mucopolysaccharidosis, type I
0.000 0.661 0.339
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.661 0.339
E77.8 Other disorders of glycoprotein metabolism
0.000 0.661 0.339
E77.1 Defects in glycoprotein degradation
0.000 0.661 0.339
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.661 0.339
E84.9 Cystic fibrosis, unspecified
0.000 0.661 0.339
E84.8 Cystic fibrosis with other manifestations
0.000 0.661 0.339
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.661 0.339
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.661 0.339
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.666 0.334
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.666 0.334
E79.1 Lesch-Nyhan syndrome
0.000 0.666 0.334
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.668 0.332
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.668 0.332
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.668 0.332
E74.2 Disorders of galactose metabolism
0.000 0.668 0.332
E74.1 Disorders of fructose metabolism
0.000 0.668 0.332
E74.0 Glycogen storage disease
0.000 0.668 0.332
E75.6 Lipid storage disorder, unspecified
0.000 0.672 0.328
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.672 0.328
E75.3 Sphingolipidosis, unspecified
0.000 0.672 0.328
E75.2 Other sphingolipidosis
0.000 0.672 0.328
E75.1 Other gangliosidosis
0.000 0.672 0.328
E75.0 GM2 gangliosidosis
0.000 0.672 0.328
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.674 0.326
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.679 0.321
E65-E68 Obesity and other hyperalimentation
0.000 0.683 0.317
E85.9 Amyloidosis, unspecified
0.000 0.687 0.313
E75.5 Other lipid storage disorders
0.000 0.688 0.312
E85.8 Other amyloidosis
0.000 0.703 0.296
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.703 0.296
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.703 0.296
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.703 0.296
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.707 0.293
E88.8 Other specified metabolic disorders
0.000 0.718 0.282
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.718 0.282
E44.1 Mild protein-energy malnutrition
0.000 0.721 0.278
E44.0 Moderate protein-energy malnutrition
0.000 0.721 0.278
E14.2 Withrenal complications
0.000 0.722 0.278
E85.3 Secondary systemic amyloidosis
0.000 0.729 0.271
E88.9 Metabolic disorder, unspecified
0.000 0.736 0.264
E88.3 Tumour lysis syndrome
0.000 0.740 0.260
K90.8 Other intestinal malabsorption
0.000 0.741 0.258
E85.4 Organ-limited amyloidosis
0.000 0.755 0.245
E88.2 Lipomatosis, not elsewhere classified
0.000 0.760 0.240
E65 Localised adiposity
0.000 0.765 0.235
E20-E35 Disorders of other endocrine glands
0.000 0.768 0.232
E67 Other hyperalimentation
0.000 0.772 0.228
E68 Sequelae of hyperalimentation
0.000 0.772 0.228
E83.5 Disorders of calcium metabolism
0.000 0.806 0.194
C85.1 B-cell lymphoma, unspecified
0.000 0.817 0.183
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.820 0.180
E24 Cushing's syndrome
0.000 0.822 0.178
E22 Hyperfunction of pituitary gland
0.000 0.823 0.177
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.827 0.173
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.828 0.172
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.833 0.166
E32 Diseases of thymus
0.000 0.833 0.166
E31 Polyglandular dysfunction
0.000 0.833 0.166
E30 Disorders of puberty, not elsewhere classified
0.000 0.833 0.166
E25 Adrenogenital disorders
0.000 0.833 0.166
E34 Other endocrine disorders
0.000 0.834 0.165
E67.8 Other specified hyperalimentation
0.000 0.836 0.163
E67.3 Hypervitaminosis D
0.000 0.836 0.163
E67.2 Megavitamin-B6 syndrome
0.000 0.836 0.163
E67.1 Hypercarotenaemia
0.000 0.836 0.163
E67.0 Hypervitaminosis A
0.000 0.836 0.163
E20 Hypoparathyroidism
0.000 0.838 0.162
E29 Testicular dysfunction
0.000 0.838 0.162
E22.1 Hyperprolactinaemia
0.000 0.846 0.154
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.850 0.150
E26 Hyperaldosteronism
0.000 0.854 0.146
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.855 0.145
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.857 0.143
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.858 0.142
E27 Other disorders of adrenal gland
0.000 0.858 0.142
E22.0 Acromegaly and pituitary gigantism
0.000 0.859 0.141
C83.3 Large cell (diffuse)
0.000 0.860 0.140
E34.9 Endocrine disorder, unspecified
0.000 0.861 0.139
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.862 0.138
E24.0 Pituitary-dependent Cushing's disease
0.000 0.862 0.138
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.862 0.138
E21.0 Primary hyperparathyroidism
0.000 0.864 0.136
E24.2 Drug-induced Cushing's syndrome
0.000 0.867 0.132
C81 Hodgkin's disease
0.000 0.869 0.131
E28 Ovarian dysfunction
0.000 0.870 0.129
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.871 0.129
C85.0 Lymphosarcoma
0.000 0.871 0.129
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.871 0.128
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.872 0.128
E24.8 Other Cushing's syndrome
0.000 0.872 0.128
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.872 0.128
E24.3 Ectopic ACTH syndrome
0.000 0.872 0.128
E24.1 Nelson's syndrome
0.000 0.872 0.128
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.873 0.127
E22.8 Other hyperfunction of pituitary gland
0.000 0.873 0.127
E50-E64 Other nutritional deficiencies
0.001 0.873 0.125
E00-E07 Disorders of thyroid gland
0.000 0.875 0.125
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.875 0.124
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.877 0.123
E21.4 Other specified disorders of parathyroid gland
0.000 0.877 0.123
E21.2 Other hyperparathyroidism
0.000 0.877 0.123
E24.9 Cushing's syndrome, unspecified
0.000 0.877 0.123
E25.9 Adrenogenital disorder, unspecified
0.000 0.880 0.119
E25.8 Other adrenogenital disorders
0.000 0.880 0.119
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.880 0.119
E30.9 Disorder of puberty, unspecified
0.000 0.880 0.119
E30.8 Other disorders of puberty
0.000 0.880 0.119
E30.1 Precocious puberty
0.000 0.880 0.119
E30.0 Delayed puberty
0.000 0.880 0.119
E31.9 Polyglandular dysfunction, unspecified
0.000 0.880 0.119
E31.8 Other polyglandular dysfunction
0.000 0.880 0.119
E31.1 Polyglandular hyperfunction
0.000 0.880 0.119
E31.0 Autoimmune polyglandular failure
0.000 0.880 0.119
E32.9 Disease of thymus, unspecified
0.000 0.880 0.119
E32.8 Other diseases of thymus
0.000 0.880 0.119
E32.1 Abscess of thymus
0.000 0.880 0.119
E32.0 Persistent hyperplasia of thymus
0.000 0.880 0.119
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.880 0.119
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.880 0.119
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.880 0.119
E34.5 Androgen resistance syndrome
0.000 0.881 0.119
E34.4 Constitutional tall stature
0.000 0.881 0.119
E34.3 Short stature, not elsewhere classified
0.000 0.881 0.119
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.881 0.119
E34.1 Other hypersecretion of intestinal hormones
0.000 0.881 0.119
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.882 0.118
C82.2 Large cell, follicular
0.000 0.883 0.117
E20.8 Other hypoparathyroidism
0.000 0.884 0.116
E20.1 Pseudohypoparathyroidism
0.000 0.884 0.116
E20.0 Idiopathic hypoparathyroidism
0.000 0.884 0.116
E29.9 Testicular dysfunction, unspecified
0.000 0.884 0.116
E29.8 Other testicular dysfunction
0.000 0.884 0.116
E29.0 Testicular hyperfunction
0.000 0.884 0.116
C81.1 Nodular sclerosis
0.000 0.885 0.115
C88 Malignant immunoproliferative diseases
0.000 0.886 0.114
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.886 0.113
C82.0 Small cleaved cell, follicular
0.000 0.887 0.113
E27.1 Primary adrenocortical insufficiency
0.000 0.888 0.112
E20.9 Hypoparathyroidism, unspecified
0.000 0.888 0.111
E78.8 Other disorders of lipoprotein metabolism
0.000 0.889 0.111
E29.1 Testicular hypofunction
0.000 0.889 0.111
E27.2 Addisonian crisis
0.000 0.892 0.108
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.892 0.107
C94 Other leukaemias of specified cell type
0.000 0.892 0.107
C93 Monocytic leukaemia
0.000 0.892 0.107
E78.1 Pure hyperglyceridaemia
0.000 0.893 0.107
C83.1 Small cleaved cell (diffuse)
0.000 0.893 0.107
C95 Leukaemia of unspecified cell type
0.000 0.894 0.106
E78.6 Lipoprotein deficiency
0.000 0.894 0.106
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.894 0.106
E34.8 Other specified endocrine disorders
0.000 0.894 0.105
E26.9 Hyperaldosteronism, unspecified
0.000 0.895 0.105
E26.8 Other hyperaldosteronism
0.000 0.895 0.105
E26.1 Secondary hyperaldosteronism
0.000 0.895 0.105
C83.7 Burkitt's tumour
0.000 0.895 0.104
C83.6 Undifferentiated (diffuse)
0.000 0.895 0.104
C83.5 Lymphoblastic (diffuse)
0.000 0.895 0.104
C83.4 Immunoblastic (diffuse)
0.000 0.895 0.104
C83.2 Mixed small and large cell (diffuse)
0.000 0.895 0.104
C82.3 Follicular lymphoma grade IIIa
0.000 0.897 0.103
C82.6 Cutaneous follicle centre lymphoma
0.000 0.897 0.103
C82.5 Diffuse follicle centre lymphoma
0.000 0.897 0.103
C82.4 Follicular lymphoma grade IIIb
0.000 0.897 0.103
E78.3 Hyperchylomicronaemia
0.000 0.898 0.102
E27.5 Adrenomedullary hyperfunction
0.000 0.898 0.102
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.898 0.102
E27.0 Other adrenocortical overactivity
0.000 0.898 0.102
E34.0 Carcinoid syndrome
0.000 0.899 0.101
C81.9 Hodgkin's disease, unspecified
0.000 0.899 0.101
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.901 0.099
C86 Other specified types of T/NK-cell lymphoma
0.000 0.902 0.098
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.904 0.096
E28.3 Primary ovarian failure
0.000 0.905 0.095
C81.7 Other Hodgkin's disease
0.000 0.906 0.094
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.906 0.094
C81.3 Lymphocytic depletion
0.000 0.906 0.094
C81.2 Mixed cellularity
0.000 0.906 0.094
C81.0 Lymphocytic predominance
0.000 0.906 0.094
E28.9 Ovarian dysfunction, unspecified
0.000 0.907 0.093
E28.8 Other ovarian dysfunction
0.000 0.907 0.093
E28.1 Androgen excess
0.000 0.907 0.093
E28.0 Oestrogen excess
0.000 0.907 0.093
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.907 0.093
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.907 0.092
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.907 0.092
E89.5 Postprocedural testicular hypofunction
0.000 0.907 0.092
E89.4 Postprocedural ovarian failure
0.000 0.907 0.092
E89.1 Postprocedural hypoinsulinaemia
0.000 0.907 0.092
E64 Sequelae of malnutrition and other nutritional deficiencies
0.001 0.909 0.090
E63 Other nutritional deficiencies
0.001 0.909 0.090
E56 Other vitamin deficiencies
0.001 0.909 0.090
E50 Vitamin A deficiency
0.001 0.909 0.090
E60 Dietary zinc deficiency
0.001 0.909 0.090
E59 Dietary selenium deficiency
0.001 0.909 0.090
E54 Ascorbic acid deficiency
0.001 0.909 0.090
E52 Niacin deficiency [pellagra]
0.001 0.909 0.090
E78.4 Other hyperlipidaemia
0.000 0.910 0.090
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.910 0.090
E00 Congenital iodine-deficiency syndrome
0.000 0.910 0.090
C83.0 Small cell (diffuse)
0.000 0.910 0.090
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.910 0.090
E06 Thyroiditis
0.000 0.910 0.090
E51 Thiamine deficiency
0.001 0.911 0.088
E27.8 Other specified disorders of adrenal gland
0.000 0.911 0.089
E21.3 Hyperparathyroidism, unspecified
0.000 0.913 0.087
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.914 0.086
E89.3 Postprocedural hypopituitarism
0.000 0.914 0.086
E26.0 Primary hyperaldosteronism
0.000 0.915 0.084
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.915 0.085
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.917 0.083
E23 Hypofunction and other disorders of pituitary gland
0.000 0.917 0.083
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.918 0.082
C88.7 Other malignant immunoproliferative diseases
0.000 0.918 0.082
C88.3 Immunoproliferative small intestinal disease
0.000 0.918 0.082
C88.2 Gamma heavy chain disease
0.000 0.918 0.082
C88.1 Alpha heavy chain disease
0.000 0.918 0.082
E58 Dietary calcium deficiency
0.001 0.921 0.078
E05.9 Thyrotoxicosis, unspecified
0.000 0.922 0.078
C93.9 Monocytic leukaemia, unspecified
0.000 0.923 0.077
C93.7 Other monocytic leukaemia
0.000 0.923 0.077
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.923 0.077
C93.2 Subacute monocytic leukaemia
0.000 0.923 0.077
C93.1 Chronic monocytic leukaemia
0.000 0.923 0.077
C93.0 Acute monocytic leukaemia
0.000 0.923 0.077
C94.7 Other specified leukaemias
0.000 0.923 0.077
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.923 0.077
C94.5 Acute myelofibrosis
0.000 0.923 0.077
C94.4 Acute panmyelosis
0.000 0.923 0.077
C94.3 Mast cell leukaemia
0.000 0.923 0.077
C94.2 Acute megakaryoblastic leukaemia
0.000 0.923 0.077
C94.1 Chronic erythraemia
0.000 0.923 0.077
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.923 0.077
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.923 0.077
C96.8 Histiocytic sarcoma
0.000 0.923 0.077
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.923 0.077
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.923 0.077
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.923 0.077
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.923 0.077
C96.3 True histiocytic lymphoma
0.000 0.923 0.077
C96.2 Malignant mast cell tumour
0.000 0.923 0.077
C96.1 Malignant histiocytosis
0.000 0.923 0.077
C96.0 Letterer-Siwe disease
0.000 0.923 0.077
C95.7 Other leukaemia of unspecified cell type
0.000 0.924 0.076
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.924 0.076
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.924 0.076
C95.0 Acute leukaemia of unspecified cell type
0.000 0.924 0.076
E06.3 Autoimmune thyroiditis
0.000 0.924 0.076
C95.9 Leukaemia, unspecified
0.000 0.925 0.075
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.927 0.073
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.929 0.070
C86.4 Blastic NK-cell lymphoma
0.000 0.929 0.070
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.929 0.070
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.929 0.070
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.929 0.070
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.929 0.070
E05.8 Other thyrotoxicosis
0.000 0.930 0.070
E27.9 Disorder of adrenal gland, unspecified
0.000 0.930 0.070
E78.2 Mixed hyperlipidaemia
0.000 0.930 0.070
E89.8 Other postprocedural endocrine and metabolic disorders
0.001 0.930 0.069
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.931 0.069
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.931 0.069
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.931 0.069
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.931 0.069
C84.3 Lymphoepithelioid lymphoma
0.000 0.931 0.069
C84.2 T-zone lymphoma
0.000 0.931 0.069
C84.1 Sezary's diease
0.000 0.931 0.069
C84.0 Mycosis fungoides
0.000 0.931 0.069
E55 Vitamin D deficiency
0.001 0.932 0.067
E05.5 Thyroid crisis or storm
0.000 0.933 0.067
E05.4 Thyrotoxicosis factitia
0.000 0.933 0.067
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.933 0.067
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.933 0.067
E50.9 Vitamin A deficiency, unspecified
0.001 0.934 0.065
E50.8 Other manifestations of vitamin A deficiency
0.001 0.934 0.065
E50.7 Other ocular manifestations of vitamin A deficiency
0.001 0.934 0.065
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.001 0.934 0.065
E50.5 Vitamin A deficiency with night blindness
0.001 0.934 0.065
E50.4 Vitamin A deficiency with keratomalacia
0.001 0.934 0.065
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.001 0.934 0.065
E50.2 Vitamin A deficiency with corneal xerosis
0.001 0.934 0.065
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.001 0.934 0.065
E50.0 Vitamin A deficiency with conjunctival xerosis
0.001 0.934 0.065
E56.9 Vitamin deficiency, unspecified
0.001 0.934 0.065
E56.8 Deficiency of other vitamins
0.001 0.934 0.065
E56.1 Deficiency of vitamin K
0.001 0.934 0.065
E56.0 Deficiency of vitamin E
0.001 0.934 0.065
E63.9 Nutritional deficiency, unspecified
0.001 0.934 0.065
E63.8 Other specified nutritional deficiencies
0.001 0.934 0.065
E63.1 Imbalance of constituents of food intake
0.001 0.934 0.065
E63.0 Essential fatty acid [EFA] deficiency
0.001 0.934 0.065
E64.9 Sequelae of unspecified nutritional deficiency
0.001 0.934 0.065
E64.8 Sequelae of other nutritional deficiencies
0.001 0.934 0.065
E64.3 Sequelae of rickets
0.001 0.934 0.065
E64.2 Sequelae of vitamin C deficiency
0.001 0.934 0.065
E64.1 Sequelae of vitamin A deficiency
0.001 0.934 0.065
E64.0 Sequelae of protein-energy malnutrition
0.001 0.934 0.065
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.935 0.065
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.935 0.065
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.935 0.065
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.935 0.065
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.935 0.065
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.935 0.065
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.935 0.065
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.935 0.065
C84.4 Peripheral T-cell lymphoma
0.000 0.935 0.065
E06.4 Drug-induced thyroiditis
0.000 0.935 0.064
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.935 0.064
E06.1 Subacute thyroiditis
0.000 0.935 0.064
E06.0 Acute thyroiditis
0.000 0.935 0.064
E51.9 Thiamine deficiency, unspecified
0.001 0.936 0.063
E51.8 Other manifestations of thiamine deficiency
0.001 0.936 0.063
E51.1 Beriberi
0.001 0.936 0.063
C84.5 Other and unspecified T-cell lymphomas
0.000 0.936 0.064
E03 Other hypothyroidism
0.000 0.937 0.063
E89.2 Postprocedural hypoparathyroidism
0.000 0.937 0.062
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.938 0.062
E51.2 Wernicke's encephalopathy
0.001 0.938 0.061
C92 Myeloid leukaemia
0.000 0.938 0.062
C90.2 Plasmacytoma, extramedullary
0.000 0.938 0.062
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.939 0.061
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.940 0.060
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.940 0.059
E23.1 Drug-induced hypopituitarism
0.000 0.940 0.059
E23.2 Diabetes insipidus
0.000 0.941 0.058
E06.5 Other chronic thyroiditis
0.000 0.942 0.058
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.944 0.056
E07 Other disorders of thyroid
0.000 0.944 0.055
E61 Deficiency of other nutrient elements
0.002 0.945 0.054
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.945 0.055
E06.9 Thyroiditis, unspecified
0.000 0.947 0.053
E23.7 Disorder of pituitary gland, unspecified
0.000 0.947 0.052
C90.1 Plasma cell leukaemia
0.000 0.947 0.052
E28.2 Polycystic ovarian syndrome
0.000 0.949 0.051
I10 Essential (primary) hypertension
0.000 0.950 0.050
E55.0 Rickets, active
0.001 0.951 0.048
E23.6 Other disorders of pituitary gland
0.000 0.951 0.048
K90-K93 Other diseases of the digestive system
0.000 0.954 0.046
E03.5 Myxoedema coma
0.000 0.955 0.045
E03.4 Atrophy of thyroid (acquired)
0.000 0.955 0.045
E03.3 Postinfectious hypothyroidism
0.000 0.955 0.045
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.955 0.045
C92.1 Chronic myeloid leukaemia
0.000 0.955 0.045
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.955 0.045
C92.7 Other myeloid leukaemia
0.000 0.955 0.045
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.955 0.045
C92.5 Acute myelomonocytic leukaemia
0.000 0.955 0.045
C92.3 Myeloid sarcoma
0.000 0.955 0.045
C92.2 Subacute myeloid leukaemia
0.000 0.955 0.045
C92.4 Acute promyelocytic leukaemia
0.000 0.958 0.042
E53 Deficiency of other B group vitamins
0.001 0.958 0.041
C92.9 Myeloid leukaemia, unspecified
0.000 0.958 0.042
E03.1 Congenital hypothyroidism without goitre
0.000 0.958 0.042
E07.1 Dyshormogenetic goitre
0.000 0.960 0.040
E07.0 Hypersecretion of calcitonin
0.000 0.960 0.040
E61.9 Deficiency of nutrient element, unspecified
0.001 0.960 0.039
E61.8 Deficiency of other specified nutrient elements
0.001 0.960 0.039
E61.7 Deficiency of multiple nutrient elements
0.001 0.960 0.039
E61.6 Vanadium deficiency
0.001 0.960 0.039
E61.5 Molybdenum deficiency
0.001 0.960 0.039
E61.4 Chromium deficiency
0.001 0.960 0.039
E61.3 Manganese deficiency
0.001 0.960 0.039

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.